Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Biotech
  • FDA
  • General
  • News

BioVie Announces Phase 2 Trial Assessing NE3107’s Pro-motoric Activity In Parkinson’s Disease Is Fully Enrolled

By Benzinga Newsdesk
October 19, 6:04 AM
BioVie Inc., (NASDAQ:BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and

BIVI

Read More
1 minute read
  • Biotech
  • General
  • News

Traders Circulate ‘Struggling Editas Shops Preclinical Cancer Pipeline During Its Big Makeover’ – Endpoints News

By Benzinga Newsdesk
October 18, 3:27 PM
EXCLUSIVE: Struggling Editas shops preclinical cancer pipeline during its big makeover – Endpoints News (endpts.com)

EDIT

Read More
4 minute read
  • FDA
  • News

FDA Injunctions Would Require The Companies And Named Individuals To Stop Manufacturing, Selling, And Distributing Their E-cigarettes; Injunctions Would Also Require The Defendants To Obtain Marketing Authorization From The FDA Before Marketing

By Benzinga Newsdesk
October 18, 2:58 PM
FDA, DOJ Seek Permanent Injunctions Against Six E-cigarette Manufacturers | FDA

MO

Read More
1 minute read
  • FDA
  • News

FDA & DOJ Seek Permanent Injunctions Against Six E-Cigarette Manufacturers; Defendants Failed To Submit Premarket Applications For E-Cigarettes And Continued To Illegally Manufacture, Sell, And Distribute Their Products

By Benzinga Newsdesk
October 18, 2:57 PM
- Reuters 

MO

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

AstraZeneca’s Evusheld Receives Health Canada Approval For Treatment Of Covid-19; Evusheld Received A Notice Of Compliance From Health Canada For Treatment Of Mild To Moderate Covid-19 In Adults And Adolescents

By Benzinga Newsdesk
October 18, 12:56 PM
- Reuters 

AZN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News

Teva Highlights Long-Term Data From Chorea Associated-Huntington’s Treatment

By Vandana Singh
October 18, 11:18 AM
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) announced results from the ARC-HD trial, an approximately 3-year open-label study evaluating the safety and tolerability…

TEVA

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Synlogic Touts Positive Data From Rare Inherited Disorder Trial, Pivotal Study To Start Next Year

By Vandana Singh
October 18, 11:15 AM
Synlogic Inc (NASDAQ:SYBX) announced topline data from the Phase 2 Synpheny-1 study in phenylketonuria (PKU), a rare inherited disorder that causes…

SYBX

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • News

Silo Pharma Extends Alzheimer’s Therapeutics Research Pact

By Vandana Singh
October 18, 10:41 AM
Silo Pharma Inc (NASDAQ:SILO) entered into an agreement with Columbia University under which Silo has been granted an extension…

SILO

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Merck Outlicenses Two Preclinical TB Candidates To Bill & Melinda Gates Research Institute

By Vandana Singh
October 18, 9:49 AM
Merck & Co Inc (NYSE:MRK) and the Bill & Melinda Gates Medical Research Institute (Gates MRI) announced a licensing…

MRK

Read More
1 minute read
  • Biotech
  • General
  • News

CbdMD Launches Powerful New Product Designed To Reduce Pain – cbdMD MAX

By Benzinga Newsdesk
October 18, 9:23 AM
Formulated with Proprietary Cannabinoid Blend and Clinically Proven Ingredient to Address Pain Charlotte, North Carolina--(Newsfile Corp. - October 18, 2022) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the

YCBD

Posts pagination

Previous 1 … 655 656 657 … 795 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service